Increasing and changing pattern of treatment switches among people with HIV
Reduced-drug treatment becoming common in Paris
Dolutegravir may increase blood clotting affecting stroke and heart attack risk, early findings warn
Intermittent dosing on HIV dual therapy leads to higher rate of treatment failure
Greater weight gain in first year of HIV treatment raises risks of diabetes, metabolic syndrome and precursors of heart disease
Very poor long-term outcomes for people with TB and HIV in Eastern Europe
Long-acting injectable version of the most popular HIV drug combination is possible
Competing priorities impact HIV treatment adherence for South Africans with low incomes
Top 5 stories on HIV in Asia from IAS 2023
